MP BIOMEDICALS, LLC

MP Biomedicals, LLC specializes in in vitro diagnostic (IVD) kits used for measuring hormones and metabolites in clinical settings. Their products include assays for neonatal thyroid stimulating hormone (TSH), estradiol, progesterone, cortisol, vitamin B12, reverse triiodothyronine (reverse T3), galactose, and aldosterone. These kits use techniques like enzyme immunoassay (EIA), radioimmunoassay (RIA), and enzyme fluorescence to detect and quantify biomarkers relevant to endocrinology, neonatology, and metabolic screening.

MP Biomedicals, LLC is based in the United States, which means their IVD devices are subject to FDA regulatory oversight. Since their products are designed for use in the U.S., they must comply with FDA requirements for in vitro diagnostics, including classification under FDA’s Class I or Class II categories and registration through systems like the 510(k) premarket notification process and the Unique Device Identifier (UDI) system.

MP Biomedicals, LLC’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries track devices that have undergone FDA review for compliance with regulatory requirements before being marketed in the U.S., ensuring transparency and traceability of their IVD kits.

MP Biomedicals, LLC’s IVD devices are classified under FDA’s Class I or Class II categories. The classification depends on the risk associated with the device’s use and intended purpose. For example, simpler diagnostic tests like some hormone assays may fall under Class I, while more complex or higher-risk assays (such as certain immunoassays) may be classified as Class II. This classification determines the regulatory pathway and compliance requirements the devices must meet before being authorized for use.